Reactome: an open knowledgebase of human pathways

Active Cooperative Agreement Awarded Last action

Award ID
U24HG012198
Recipient
Awarding agency
Obligated
$13,762,364

Award facts

Assistance listing
93.172 Human Genome Research
Completion date 87% complete
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

Description

Abstract
We seek renewal of the core operating funding for the reactome knowledgebase. Reactome is a manually curated, peer-reviewed open access biological pathway knowledgebase that can be publicly used and redistributed by all biological research community members. The reactome knowledgebase is used by academic, nonprofit and for-profit entities worldwide. Specifically, reactome is employed by genomics and proteomics researchers, clinicians, geneticists, and molecular biologists to interpret the results of large-scale omics screening projects, by data scientists and bioinformaticians to develop novel approaches for knowledge discovery and mining, and by systems biologists to build predictive models of normal and disease pathways for drug discovery. Our curators, PHD-level scientists, work closely with independent investigators within the community to assemble human- and machine-readable descriptions of human biological pathways manually using dedicated software tools. Each pathway is checked and peer-reviewed prior to publication to ensure its factual accuracy and compliance with the data model. A system of evidence tracking ensures that all assertions are supported by the primary literature. Reactome uses community-standard controlled vocabularies and ontologies to increase interoperability across resources. Pathways are reviewed and updated regularly. Reactome pathways are available on our web site for browsing, downloading, and manipulation by in-house and third-party online analysis tools. The project is highly cited in the literature, has been used repeatedly to make significant biological discoveries, and is incorporated into a large number of high-impact computational tools and resources. Over the next five years, we will: (1) efficiently curate normal and disease processes, and effects of genetic variation and drugs on protein function; (2) improve pathway data analysis and input tools to increase the curation efficiency and the utility of reactome data in large-scale biological data science projects; (3) enhance the open reactome platform; and (4) conduct active outreach efforts to facilitate user engagement, community feedback, and adoption of reactome.

Transactions

Action Obligated Date
Amendment $1,145,778
Amendment $279,599
Amendment $331,884
Amendment $331,884
Amendment $661,381
Amendment $661,381
Amendment $0
Amendment $0
Amendment $0
Amendment $1,272,864
Amendment $1,272,864
Amendment $1,272,864
Amendment $93,743
Amendment Introducing CI/CD technologies to optimize software development in reactome $174,458
Amendment $1,533,353
Amendment Introducing CI/CD technologies to optimize software development in reactome $1,533,353
Amendment $68,641
Amendment $68,641
Amendment $68,641
Amendment $68,641
Amendment $1,461,197
Original award $1,461,197
Show all 22

Quick answers

Who received award U24HG012198?

U24HG012198 was awarded to Ontario Institute For Cancer Research Institut Ontarien De Recherche SUR LE Cancer by National Human Genome Research Institute (National Institutes of Health) on August 18, 2022.

How much is award U24HG012198 worth?

$13,762,364 has been obligated on U24HG012198.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award